Top

Published in:

01-08-2015 | Research Article

Prognostic significance of Ku80 in pT2N0M0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy

Authors: Shuai Wang, Zhou Wang, Xiangyan Liu, Yu Yang, Mo Shi, Zhenguo Sun

Published in: Tumor Biology | Issue 8/2015

Abstract

Recent studies have shown that Ku80, a DNA repair protein, was involved in progression of malignant tumors. This study aimed to clarify the clinicopathological significance and prognostic value of Ku80 in pT2N0M0 esophageal squamous cell carcinoma (ESCC). We enrolled 217 patients with pT2N0M0 midthoracic ESCC who had undergone Ivor-Lewis esophagectomy. The expression profile of Ku80 was examined by immunohistochemistry. The results were correlated with the clinicopathological variables, overall survival (OS) and disease-free survival (DFS), in pT2N0M0 ESCC patients. The expression of Ku80 were higher in ESCC tissues than the corresponding health esophageal mucosa (P < 0.001). Clinically, the Ku80 expression levels were significantly related to tumor size (P = 0.018), differentiation degree (P = 0.010), and tumor-node-metastasis (TNM) stage (P = 0.001). Subsequent multivariate analysis demonstrated that tumor size, differentiation degree, TNM stage, and Ku80 expression were independent prognostic factors for the OS and the DFS of pT2N0M0 ESCC patients. Our data indicated that Ku80 expression level associates with key clinicopathological features and is an independent predictor of the OS and the DFS in pT2N0M0 ESCC patients.

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. Estimates of worldwide burden of cancer in 2008. GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917. doi:10.1002/ijc.25516.CrossRefPubMed

Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol. 2007;8:545–53.CrossRefPubMed

Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–50.CrossRefPubMed

D’Annoville T, D’Journo XB, Loundou A, Trousse D, Dahan L, et al. Prognostic impact of the extracapsular lymph node involvement on disease-free survival according to the 7th edition of American Joint Committee on Cancer Staging System. Eur J Cardiothorac Surg. 2013;44:e207–11. doi:10.1093/ejcts/ezt332.CrossRefPubMed

Hou X, Wei JC, Fu JH, Wang X, Zhang LJ, et al. Proposed modification of the seventh American Joint Committee on Cancer staging system for esophageal squamous cell carcinoma in Chinese patients. Ann Surg Oncol. 2014;21:337–42. doi:10.1245/s10434-013-3265-2.CrossRefPubMed

Chen G, Wang Z, Liu XY, Liu FY. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma? Ann Thorac Surg. 2009;87:1697–702. doi:10.1016/j.athoracsur.2009.03.060.CrossRefPubMed

Song Y, Wang Z, Liu X, Jiang W, Shi M. CCR7 and VEGF-C: molecular indicator of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy? Ann Surg Oncol. 2012;19:3606–12. doi:10.1245/s10434-012-2419-y.CrossRefPubMed

Kamangar F, Chow WH, Abnet CC, Dawsey SM. Environmental causes of esophageal cancer. Gastroenterol Clin North Am. 2009;38:27–57. doi:10.1016/j.gtc.2009.01.004.CrossRefPubMedPubMedCentral

Tuteja R, Tuteja N. Ku autoantigen: a multifunctional DNA-binding protein. Crit Rev Biochem Mol Biol. 2000;35:1–33.CrossRefPubMed

10.

Tong WM, Cortes U, Hande MP, Ohgaki H, Cavalli LR, et al. Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation. Cancer Res. 2002;62:6990–6.PubMed

11.

Gao Y, Ferguson DO, Xie W, Manis JP, Sekiguchi J, et al. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature. 2000;404:897–900.CrossRefPubMed

12.

Groselj B, Kerr M, Kiltie AE. Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression. Radiother Oncol. 2013;108:429–33. doi:10.1016/j.radonc.2013.06.021.CrossRefPubMedPubMedCentral

13.

Kruer TL, Cummins TD, Powell DW, Wittliff JL. Characterization of estrogen response element binding proteins as biomarkers of breast cancer behavior. Clin Biochem. 2013;46:1739–46. doi:10.1016/j.clinbiochem.2013.07.005.CrossRefPubMed

14.

Lim JW, Kim H, Kim KH. Expression of Ku70 and Ku80 mediated by NF-kappa B and cyclooxygenase-2 is related to proliferation of human gastric cancer cells. J Biol Chem. 2002;277:46093–100.CrossRefPubMed

15.

Hosoi Y, Watanabe T, Nakagawa K, Matsumoto Y, Enomoto A, et al. Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Int J Oncol. 2004;25:461–8.PubMed

16.

Yang QS, Gu JL, Du LQ, Jia LL, Qin LL, et al. ShRNA-mediated Ku80 gene silencing inhibits cell proliferation and sensitizes to gamma-radiation and mitomycin C-induced apoptosis in esophageal squamous cell carcinoma lines. J Radiat Res. 2008;49:399–407.CrossRefPubMed

17.

Chen G, Wang Z, Liu XY, Zhang MY, Liu FY. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the midthoracic esophagus. Eur J Cardiothorac Surg. 2009;35:1–7.CrossRefPubMed

18.

Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 7th ed. Oxford: Wiley-Blackwell; 2009.

19.

Koike M, Shiomi T, Koike A. Dimerization and nuclear localization of ku proteins. J Biol Chem. 2001;276:11167–73.CrossRefPubMed

20.

Wang Z, Liu XY, Liu FY, Chen JH. A study of correlation between early postoperative relapse with lymph node micrometastasis in patients with N0 esophageal cancer. Zhonghua Wai Ke Za Zhi. 2004;42:68–71.PubMed

21.

Ma Q, Li P, Xu M, Yin J, Su Z, et al. Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance. J Exp Clin Cancer Res. 2012;31:99. doi:10.1186/1756-9966-31-99.CrossRefPubMedPubMedCentral

22.

Alshareeda AT, Negm OH, Albarakati N, Green AR, Nolan C, et al. Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer. Breast Cancer Res Treat. 2013;139:301–10. doi:10.1007/s10549-013-2542-x.CrossRefPubMed

23.

Soderlund Leifler K, Queseth S, Fornander T, Askmalm MS. Low expression of Ku70/80, but high expression of DNAPKcs, predict good response to radiotherapy in early breast cancer. Int J Oncol. 2010;37:1547–54.PubMed

24.

Grabsch H, Dattani M, Barker L, Maughan N, Maude K, et al. Expression of DNA double-strand break repair proteins ATM and BRCA1 predicts survival in colorectal cancer. Clin Cancer Res. 2006;12:1494–500.CrossRefPubMed

25.

Komuro Y, Watanabe T, Hosoi Y, Matsumoto Y, Nakagawa K, et al. The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma. Cancer. 2002;95:1199–205.CrossRefPubMed

26.

Monferran S, Paupert J, Dauvillier S, Salles B, Muller C. The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9. EMBO J. 2004;23:3758–68.CrossRefPubMedPubMedCentral

27.

Teoh G, Urashima M, Greenfield EA, Nguyen KA, Lee JF, et al. The 86-kD subunit of Ku autoantigen mediates homotypic and heterotypic adhesion of multiple myeloma cells. J Clin Invest. 1998;101:1379–88.CrossRefPubMedPubMedCentral

28.

Muller C, Paupert J, Monferran S, Salles B. The double life of the Ku protein: facing the DNA breaks and the extracellular environment. Cell Cycle. 2005;4:438–41.CrossRefPubMed

29.

Aleskandarany M, Caracappa D, Nolan CC, Macmillan RD, Ellis IO, et al. DNA damage response markers are differentially expressed in BRCA-mutated breast cancers. Breast Cancer Res Treat. 2015;150:81–90.CrossRefPubMedPubMedCentral

30.

Green AR, Caracappa D, Benhasouna AA, Alshareeda A, Nolan CC, et al. Biological and clinical significance of PARP1 protein expression in breast cancer. Breast Cancer Res Treat. 2015;149:353–62.CrossRefPubMed

31.

Lu Y, Gao J, Lu Y. Downregulated Ku70 and ATM associated to poor prognosis in colorectal cancer among Chinese patients. Oncol Targets Ther. 2014;7:1955–61.CrossRef

Title: Prognostic significance of Ku80 in pT2N0M0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy
Authors: Shuai Wang
Zhou Wang
Xiangyan Liu
Yu Yang
Mo Shi
Zhenguo Sun
Publication date: 01-08-2015
Publisher: Springer Netherlands
Published in: Tumor Biology / Issue 8/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-015-3302-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2015

NFKB1/NFKBIa polymorphisms are associated with the progression of cervical carcinoma in HPV-infected postmenopausal women from rural area

Synergistic effect between celecoxib and luteolin is dependent on estrogen receptor in human breast cancer cells

Antagomir-1290 suppresses CD133+ cells in non-small cell lung cancer by targeting fyn-related Src family tyrosine kinase

Ceramide production mediates cinobufotalin-induced growth inhibition and apoptosis in cultured hepatocellular carcinoma cells

Vascular invasion in hepatitis B virus-related hepatocellular carcinoma with underlying cirrhosis: possible associations with ascites and hepatitis B viral factors?

A Huaier polysaccharide reduced metastasis of human hepatocellular carcinoma SMMC-7721 cells via modulating AUF-1 signaling pathway

Keynote webinar | Spotlight on antibody–drug conjugates in cancer